
Results
2
2 companies
Newron Pharmaceuticals
Market Cap: CHF 398.3m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NWRN
CHF 19.90
7D
4.2%
1Y
96.6%
Cosmo Pharmaceuticals
Market Cap: CHF 1.8b
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPN
CHF 115.40
7D
0.9%
1Y
79.5%